Evidence map›Paper›PMID 32206431›Full record

ArticleBiomedical optics express2020

Towards real-time wide-field fluorescence lifetime imaging of 5-ALA labeled brain tumors with multi-tap CMOS cameras.

David Reichert, Mikael T Erkkilä, Gerhard Holst, Nancy Hecker-Denschlag, Marco Wilzbach, Christoph Hauger, Wolfgang Drexler, Johanna Gesperger, Barbara Kiesel, Thomas Roetzer and 4 more

Abstract read
In one paragraph

Article in Biomedical optics express, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

David ReichertMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, 1090 Vienna, Austria.ORCID https://orcid.org/0000-0002-9593-6447
Mikael T ErkkiläMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, 1090 Vienna, Austria.
Gerhard HolstPCO AG, Science and Research, 93309 Kelheim, Germany.
Nancy Hecker-DenschlagCarl Zeiss Meditec AG, 73447 Oberkochen, Germany.
Marco WilzbachCarl Zeiss Meditec AG, 73447 Oberkochen, Germany.
Christoph HaugerCarl Zeiss Meditec AG, 73447 Oberkochen, Germany.
Wolfgang DrexlerMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, 1090 Vienna, Austria.
Johanna GespergerMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, 1090 Vienna, Austria.
Barbara KieselGeneral Hospital and Medical University of Vienna, Department of Neurosurgery, 1090 Vienna, Austria.
Thomas RoetzerGeneral Hospital and Medical University of Vienna, Institute of Neurology, 1090 Vienna, Austria.
Angelika UnterhuberMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, 1090 Vienna, Austria.ORCID https://orcid.org/0000-0002-1251-3001
Georg WidhalmGeneral Hospital and Medical University of Vienna, Department of Neurosurgery, 1090 Vienna, Austria.
Rainer A LeitgebMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, 1090 Vienna, Austria.
Marco AndreanaMedical University of Vienna, Center for Medical Physics and Biomedical Engineering, 1090 Vienna, Austria.ORCID https://orcid.org/0000-0002-8212-0545

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluorescence guided neurosurgery based on 5-aminolevulinic acid (5-ALA) has significantly increased maximal safe resections. Fluorescence lifetime imaging (FLIM) of 5-ALA could further boost this development by its increased sensitivity. However, neurosurgeons require real-time visual feedback which was so far limited in dual-tap CMOS camera based FLIM. By optimizing the number of phase frames required for reconstruction, we here demonstrate real-time 5-ALA FLIM of human high- and low-grade glioma with up to 12 Hz imaging rate over a wide field of view (11.0 x 11.0 mm). Compared to conventional fluorescence imaging, real-time FLIM offers enhanced contrast of weakly fluorescent tissue.

Identifiers

PMID32206431
PMCPMC7075617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.